{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:25:30Z","timestamp":1790007930874,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.amjopharm.2011.02.003","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T00:07:36Z","timestamp":1301702856000},"page":"80-87","source":"Crossref","is-referenced-by-count":10,"title":["Potentially Procholinergic Effects of Medications Commonly Used in Older Adults"],"prefix":"10.1016","volume":"9","author":[{"given":"Kenneth","family":"Rockwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.02.003_bib1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1532-5415.1991.tb02875.x","article-title":"Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?","volume":"39","author":"Carbonin","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","article-title":"Anticholinergic drugs and physical function among frail elderly population","volume":"81","author":"Landi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib4","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.clpt.6100303","article-title":"Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women","volume":"83","author":"Cao","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00019442-200307000-00009","article-title":"Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease","volume":"11","author":"Lu","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase ihibitors for Alzheimer's disease","volume":"1","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00002093-200304000-00011","article-title":"Inhibition of human cholinesterases by drugs used to treat Alzheimer disease","volume":"17","author":"Darvesh","year":"2003","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clinbiochem.2003.09.004","article-title":"Differential effects of lipid-lowering agents on human cholinesterases","volume":"37","author":"Darvesh","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1287\/inte.28.5.29","article-title":"Design and use of the Microsoft Excel Solver","volume":"28","author":"Fylstra","year":"1998","journal-title":"Interfaces"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1023042418784","article-title":"Interval methods for accelerated global search in the Microsoft Excel Solver","volume":"9","author":"Nenov","year":"2003","journal-title":"Reliab Comput"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/awn326","article-title":"Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease","volume":"132","author":"Smith","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.clinthera.2010.06.019","article-title":"Effectiveness and tolerability of high-dose (23 mg\/d) versus standard-dose (10 mg\/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study","volume":"32","author":"Farlow","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjopharm.2011.02.003_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ddr.430120302","article-title":"Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: Clinical, pharmacological, and therapeutic aspects","volume":"12","author":"Becker","year":"1988","journal-title":"Drug Development Res"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T20:51:10Z","timestamp":1543870270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1543594611000079"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.02.003","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}